293 related articles for article (PubMed ID: 21519057)
1. Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid.
Gu X; Mei F; Liu Y; Zhang R; Zhang J; Ma Z
Anesth Analg; 2011 Aug; 113(2):405-11. PubMed ID: 21519057
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal injection of JWH015 attenuates remifentanil-induced postoperative hyperalgesia by inhibiting activation of spinal glia in a rat model.
Sun Y; Zhang W; Liu Y; Liu X; Ma Z; Gu X
Anesth Analg; 2014 Apr; 118(4):841-53. PubMed ID: 24651239
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal administration of roscovitine attenuates cancer pain and inhibits the expression of NMDA receptor 2B subunit mRNA.
Zhang R; Liu Y; Zhang J; Zheng Y; Gu X; Ma Z
Pharmacol Biochem Behav; 2012 Jul; 102(1):139-45. PubMed ID: 22503970
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal injection of the peptide myr-NR2B9c attenuates bone cancer pain via perturbing N-methyl-D-aspartate receptor-PSD-95 protein interactions in mice.
Liu Y; Cui X; Sun YE; Yang X; Ni K; Zhou Y; Ma Z; Gu X
Anesth Analg; 2014 Jun; 118(6):1345-54. PubMed ID: 24842180
[TBL] [Abstract][Full Text] [Related]
5. The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain.
Gu X; Zhang J; Ma Z; Wang J; Zhou X; Jin Y; Xia X; Gao Q; Mei F
Eur J Pain; 2010 May; 14(5):496-502. PubMed ID: 19815434
[TBL] [Abstract][Full Text] [Related]
6. Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats.
Zhang M; Wang K; Ma M; Tian S; Wei N; Wang G
Anesth Analg; 2016 Apr; 122(4):1031-7. PubMed ID: 26720619
[TBL] [Abstract][Full Text] [Related]
7. [Role of cannabinoid 2 receptor in the development of bone cancer pain].
Wang D; Ren BX; Liu CL; Zhu J; Zhang J; Zhang W; Mei FM; Gu XP; Ma ZL
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):440-3. PubMed ID: 22490961
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor 2‑selective agonist JWH015 attenuates bone cancer pain through the amelioration of impaired autophagy flux induced by inflammatory mediators in the spinal cord.
Mao Y; Huang Y; Zhang Y; Wang C; Wu H; Tian X; Liu Y; Hou B; Liang Y; Rong H; Gu X; Ma Z
Mol Med Rep; 2019 Dec; 20(6):5100-5110. PubMed ID: 31661120
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the spinal NMDA receptor/PKCγ signaling pathway in the development of bone cancer pain.
Xiaoping G; Xiaofang Z; Yaguo Z; Juan Z; Junhua W; Zhengliang M
Brain Res; 2010 Jun; 1335():83-90. PubMed ID: 20362561
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model.
Ren BX; Gu XP; Zheng YG; Liu CL; Wang D; Sun YE; Ma ZL
Anesthesiology; 2012 Jan; 116(1):122-32. PubMed ID: 22123524
[TBL] [Abstract][Full Text] [Related]
11. Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision.
Romero-Sandoval A; Eisenach JC
Anesthesiology; 2007 Apr; 106(4):787-94. PubMed ID: 17413917
[TBL] [Abstract][Full Text] [Related]
12. Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.
Curto-Reyes V; Llames S; Hidalgo A; Menéndez L; Baamonde A
Br J Pharmacol; 2010 Jun; 160(3):561-73. PubMed ID: 20233215
[TBL] [Abstract][Full Text] [Related]
13. A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2.
Lu C; Shi L; Sun B; Zhang Y; Hou B; Sun Y; Ma Z; Gu X
Cell Mol Neurobiol; 2017 Jan; 37(1):101-109. PubMed ID: 26935064
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal injection of selected peptide Myr-RC-13 attenuates bone cancer pain by inhibiting KIF17 and NR2B expression.
Ni K; Zhou Y; Sun YE; Liu Y; Gu XP; Ma ZL
Pharmacol Biochem Behav; 2014 Jul; 122():228-33. PubMed ID: 24726705
[TBL] [Abstract][Full Text] [Related]
15. The effect of NR2B subunit palmitoylation at the spinal level after chronic dorsal root ganglia compression in rats.
Xia T; Cui Y; Shi H; Ma Z; Gu X
Anesth Analg; 2014 Nov; 119(5):1208-14. PubMed ID: 25089731
[TBL] [Abstract][Full Text] [Related]
16. Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury.
Romero-Sandoval A; Nutile-McMenemy N; DeLeo JA
Anesthesiology; 2008 Apr; 108(4):722-34. PubMed ID: 18362605
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice.
Curto-Reyes V; Boto T; Hidalgo A; Menéndez L; Baamonde A
Eur J Pharmacol; 2011 Oct; 668(1-2):184-9. PubMed ID: 21771590
[TBL] [Abstract][Full Text] [Related]
18. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
[TBL] [Abstract][Full Text] [Related]
19. Ifenprodil induced antinociception and decreased the expression of NR2B subunits in the dorsal horn after chronic dorsal root ganglia compression in rats.
Zhang W; Shi CX; Gu XP; Ma ZL; Zhu W
Anesth Analg; 2009 Mar; 108(3):1015-20. PubMed ID: 19224818
[TBL] [Abstract][Full Text] [Related]
20. The role of nitric oxide in the local antiallodynic and antihyperalgesic effects and expression of delta-opioid and cannabinoid-2 receptors during neuropathic pain in mice.
Hervera A; Negrete R; Leánez S; Martín-Campos J; Pol O
J Pharmacol Exp Ther; 2010 Sep; 334(3):887-96. PubMed ID: 20498253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
